CED Clinic
  • What to Expect
    • Your First Visit
    • Patient Intake Form
  • Services Offered
    • Telemedicine
    • Pediatric Patients
    • Additional Services
  • Registration Resources
    • Registration Help
    • Next Steps
    • Caregiver Information
    • Cannabis Control Commission
  • Contact
    • Contact the Clinic
    • Social Media Links
    • Review Us!
    • Meet The Team >
      • Meet Dr. Caplan
      • Meet Dr. Exelbert
  • CED Clinic Events
    • Upcoming Events
    • Fireside Chats
    • Dispensary Highlights
    • Past Events
  • Information and FAQ
    • CED Clinic Cannabis Care
    • Cannabis FAQ
    • Recommended Online Resources
    • Patient Stories
    • CED Library
    • Printable Handouts >
      • Cannabis Journal
      • General Cannabis Info
      • Handouts for Illnesses >
        • Infectious Diseases
        • Mental Health
        • Skin Conditions
        • Neurological Disorders
        • Muscular and Skeletal Pain
        • Illnesses of Aging
        • Reproductive Health
        • Gastrointestinal Health
    • Awesome Extras! >
      • Vaporizing Overview
      • Unique Cannabinoids
      • MA Dispensary Map
      • Cannabis for Sleep
      • Topical Cannabis Products
      • Cooking with Cannabis
      • Cannabis Cookbook
  • Video Library
  • Massachusetts Dispensaries
  • Site Map
  • CED Blog
  • Blog
  • Socials
  • CED Clinic Services

CED Blog

Use the search bar above to explore our blog articles! 

Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications

5/10/2021

0 Comments

 
Picture
Nabilone, a synthetic compound that mimics THC - the main psychoactive constituent of the plant cannabis, is a medication indicated for preventing nausea and vomiting in cancer patients. In ongoing clinical trials, it has also demonstrated efficacy for several other conditions, most noticeably the treatment of insomnia and nightmares in patients with psychiatric disorders, the management of chronic pain, and harm reduction in marijuana dependence. These various benefits make nabilone a promising medication for managing concurrent disorders. Aware of such values, researchers from the Department of Psychiatry, University of Ottawa and the Integrated Forensic Program, Royal Ottawa Health Care Group examined the effectiveness of nabilone in treating a seriously mentally ill correctional population with multiple diagnoses.
The study was conducted at the St Lawrence Valley Correctional and Treatment Centre, a hybrid mental health and correctional center. One hundred and four male inmates with concurrent serious mental illnesses were prescribed nabilone and the indications, efficacy, and safety of its use were evaluated. Results showed that patients experienced significant improvement in PTSD-associated insomnia, nightmares, and chronic pain. Furthermore, on average, nabilone alleviated 3.5 conditions per patient, thus reducing the need for multiple medications. Also worth noticing was that there was no evidence of nabilone abuse within this high-risk population and following initiation of nabilone, many patients were able to discontinue the use of medications associated with greater risk for adverse effects or abuse, such as antipsychotics and sedative/hypnotics. 
Together, these findings corroborate the potential of nabilone as a safe, effective treatment for patients with concurrent mental disorders in correctional facilities. 
read the study here
0 Comments



Leave a Reply.

    Archives

    December 2021
    November 2021
    October 2021
    September 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    July 2019

    Categories

    All
    Adolescent
    Alcohol
    Analgesic
    Antitumor
    Anxiety
    Arthritis
    Athletes
    Australia
    Benzodiazepines
    Bioflavonoids
    Brain
    Breast Cancer
    Canada
    Cancer
    Cannabidiol
    Cannabinoid
    Cannabinoid Receptor 1
    Cannabinoid Receptor 2
    Cannabinoids
    Cannabis
    Cardiovascular
    CB1
    CB2
    CBD
    CBG
    CBN
    CBT
    Cessation
    Cholesterol
    Chronic Pain
    Clinical
    Cognitive
    Cognitive Health
    Colorado
    Consumption
    Coronavirus
    COVID 19
    COVID-19
    Curcumin
    Cytokine-induced Killer Cells
    Decarboxylation
    Dependence
    Diet
    Dispensaries
    Drug Abuse
    ECS
    Edibles
    Endocannabinoid System
    Entourage Effect
    Epilepsy
    Fasciae
    Fatty Acid
    FDA
    Feline
    Female Reproductive System
    Females
    Fibromyalgia
    Flavonoids
    Football
    Gastroenterology
    Growing
    Heart Disease
    Hemp
    History
    Hospitalization
    Hypothermia
    Illicit
    Industry
    Inflammation
    Injury
    Insomnia
    Israel
    Law
    Legalization
    Lung Cancer
    Male
    Marketing
    Massachusetts
    #MDTake
    Medical Cannabis
    Memory
    Men's Health
    Mental Health
    Metabolomics
    Mice
    Microdosing
    Military
    Multiple Myeloma
    Multiple Sclerosis
    Musculoskeletal
    Myofascial Tissue
    Neurodegenerative Conditions
    Neurological
    Neuroprotective Effect
    Neuropsychiatric Disorders
    NFL
    Nicotine
    Non-Cannabis Plant
    Norway
    Obesity
    Olfactory Ciruit
    Opioids
    Pain Relief
    Parkinson's Disease
    Pediatrics
    Pelvic Pain
    Pets
    Physical Activity
    Plant
    Pregnancy
    Prenatal
    Psoriasis
    Psychiatric
    Psychosis
    PTSD
    Public Health
    Recreational Cannabis
    Relaxing
    Respiratory
    Rheumatic Diseases
    Saliva
    Schizophrenia
    Seizures
    Seniors
    Sexual Intercourse
    Skin
    Smell
    Smoking
    Social Supports
    Spain
    Spinal Cord
    Sports
    Substance Abuse
    Suicide
    Synthetic
    Teratological
    Terpenes
    Tetrahydrocannabinol
    THC
    Therapy
    Tobacco
    Trauma
    UV Irradiation
    Vaping
    Veterans
    Women's Health
    Young Adults

    RSS Feed

Home

Need Registration Help?

Services Offered

Dispensaries

Contact the Clinic

Request Appointment
Copyright © 2022
  • What to Expect
    • Your First Visit
    • Patient Intake Form
  • Services Offered
    • Telemedicine
    • Pediatric Patients
    • Additional Services
  • Registration Resources
    • Registration Help
    • Next Steps
    • Caregiver Information
    • Cannabis Control Commission
  • Contact
    • Contact the Clinic
    • Social Media Links
    • Review Us!
    • Meet The Team >
      • Meet Dr. Caplan
      • Meet Dr. Exelbert
  • CED Clinic Events
    • Upcoming Events
    • Fireside Chats
    • Dispensary Highlights
    • Past Events
  • Information and FAQ
    • CED Clinic Cannabis Care
    • Cannabis FAQ
    • Recommended Online Resources
    • Patient Stories
    • CED Library
    • Printable Handouts >
      • Cannabis Journal
      • General Cannabis Info
      • Handouts for Illnesses >
        • Infectious Diseases
        • Mental Health
        • Skin Conditions
        • Neurological Disorders
        • Muscular and Skeletal Pain
        • Illnesses of Aging
        • Reproductive Health
        • Gastrointestinal Health
    • Awesome Extras! >
      • Vaporizing Overview
      • Unique Cannabinoids
      • MA Dispensary Map
      • Cannabis for Sleep
      • Topical Cannabis Products
      • Cooking with Cannabis
      • Cannabis Cookbook
  • Video Library
  • Massachusetts Dispensaries
  • Site Map
  • CED Blog
  • Blog
  • Socials
  • CED Clinic Services